Kerckhove_2022_BMC.Cancer_22_742

Reference

Title : Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial - Kerckhove_2022_BMC.Cancer_22_742
Author(s) : Kerckhove N , Tougeron D , Lepage C , Pezet D , Le Malicot K , Pelkowski M , Pereira B , Balayssac D
Ref : BMC Cancer , 22 :742 , 2022
Abstract : Kerckhove_2022_BMC.Cancer_22_742
ESTHER : Kerckhove_2022_BMC.Cancer_22_742
PubMedSearch : Kerckhove_2022_BMC.Cancer_22_742
PubMedID: 35799138

Related information

Citations formats

Kerckhove N, Tougeron D, Lepage C, Pezet D, Le Malicot K, Pelkowski M, Pereira B, Balayssac D (2022)
Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
BMC Cancer 22 :742

Kerckhove N, Tougeron D, Lepage C, Pezet D, Le Malicot K, Pelkowski M, Pereira B, Balayssac D (2022)
BMC Cancer 22 :742